AIDSWEEKLY Plus; Monday, May 14, 2007
Staff Medical Writers

Earlier this year, President Jammeh began applying his treatment to a handful of patients who had been doing well on antiretroviral therapy but stopped taking the drugs in order to qualify to receive his "cure."

HIVMA joins its colleagues in the International AIDS Society and the Society for AIDS in Africa in expressing great concern regarding this practice. "There currently is no cure for HIV/AIDS," said HIVMA Chair Daniel R. Kuritzkes, MD. "President Jammeh is giving people false hope, while at the same time making them stop treatment that has been demonstrated to save lives."

"Any treatment that claims to alleviate this devastating disease must be subjected to rigorous scientific scrutiny," he added. "A growing body of evidence from Africa shows the lifesaving effects of antiretroviral medicines for people living with HIV/AIDS. On the other hand, the remedy President Jammeh is promoting is untested. It is highly unethical to stop a proven therapy to try an unproven one. We are extremely concerned that President Jammeh would recklessly experiment with his people’s lives."

"We support the tireless efforts of African scientists, clinicians, and community health workers providing antiretroviral treatment to communities that are so deeply affected by this disease." Dr. Kuritzkes added. "We urge the government of the Gambia to support their efforts as well."

Dr. Kuritzkes concluded, "People around the world living with HIV/AIDS deserve safe, effective, and affordable treatment, regardless of the source. If President Jammeh’s remedy is as effective as he claims, it will stand up to examination. In the meantime, we urge patients receiving his unproven herbal remedy to resume taking their antiretroviral medications, which have a well-established track record of saving lives in Africa."

Keywords: HIV/AIDS, AIDS, Acquired Immunodeficiency Syndrome, Antivirals, HIV, Human Immunodeficiency Virus, Virology, HIV Medicine Association.

This article was prepared by AIDS Weekly editors from staff and other reports.

2007-05-14
AW070504

Copyright © 2007 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.